Lui, Arthur
Mulder, Karen
Brezden-Masley, Christine
Vickers, Michael
Monzon, Jose
Kennecke, Hagen
Goel, Rakesh
Vos, Larissa
Ghosh, Sunita
Marginean, Horia
Fields, Anthony
Maroun, Jean
Spratlin, Jennifer
Funding for this research was provided by:
Roche
Sanofi
Article History
Received: 9 March 2018
Accepted: 27 March 2018
First Online: 4 May 2018
Compliance with ethical standards
:
: Karen Mulder has consulting or advisory role from Novartis, Lilly and LEO Pharma, research funding from Amgen, Roche, Bayer, & Sanofi Canada; Christine Brezden-Masley has honoraria from Roche, consulting or advisory role from Roche, research funding from Roche; Michael Vickers has honoraria from Ipsen, Lilly, Novartis, & Celgene, consulting or advisory role from AstraZeneca; Jose Monzon has consulting or advisory role from Bristol-Myers Squibb, Celgene, Merck, Novartis, & Roche, speakers’ bureau from Bristol-Myers Squibb & Merck; Jennifer Spratlin has honoraria from Lilly, Celgene Taiho & Astellas, consulting or advisory role from Lilly, Celgene, Taiho & Astellas, and research funding from Sanofi, Roche, & Celgene. All other authors have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.